Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Hiesinger W, Goldstone AB, Woo YJ.

Trends Cardiovasc Med. 2012 Aug;22(6):139-44. doi: 10.1016/j.tcm.2012.07.010. Review.

2.

Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta NA, Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Muenzer JR, Yang EC, Levit RD, Yuan LJ, Macarthur JW, Saven JG, Woo YJ.

Circulation. 2011 Sep 13;124(11 Suppl):S18-26. doi: 10.1161/CIRCULATIONAHA.110.009431.

3.

Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1174-80. doi: 10.1016/j.jtcvs.2010.08.012.

4.

Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Macarthur JW Jr, Cohen JE, McGarvey JR, Shudo Y, Patel JB, Trubelja A, Fairman AS, Edwards BB, Hung G, Hiesinger W, Goldstone AB, Atluri P, Wilensky RL, Pilla JJ, Gorman JH 3rd, Gorman RC, Woo YJ.

Circ Res. 2014 Feb 14;114(4):650-9. doi: 10.1161/CIRCRESAHA.114.302884.

5.

Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G.

Blood. 2004 Apr 1;103(7):2452-9.

6.

Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Herberg S, Fulzele S, Yang N, Shi X, Hess M, Periyasamy-Thandavan S, Hamrick MW, Isales CM, Hill WD.

Tissue Eng Part A. 2013 Jan;19(1-2):1-13. doi: 10.1089/ten.TEA.2012.0085.

7.

Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.

Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR 3rd, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ.

J Thorac Cardiovasc Surg. 2012 Apr;143(4):962-6. doi: 10.1016/j.jtcvs.2011.12.028.

8.
9.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049.

10.

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.

Chu CY, Cha ST, Lin WC, Lu PH, Tan CT, Chang CC, Lin BR, Jee SH, Kuo ML.

Carcinogenesis. 2009 Feb;30(2):205-13. doi: 10.1093/carcin/bgn228.

PMID:
18849299
11.

Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer.

Kim DH, Seo YK, Thambi T, Moon GJ, Son JP, Li G, Park JH, Lee JH, Kim HH, Lee DS, Bang OY.

Biomaterials. 2015 Aug;61:115-25. doi: 10.1016/j.biomaterials.2015.05.025.

PMID:
26001076
13.

Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.

Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, Zhang J.

Tissue Eng. 2007 Aug;13(8):2063-71.

PMID:
17518719
14.

Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation.

Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM, Yarchoan R, Tosato G.

Blood. 2005 Jun 15;105(12):4561-8.

15.

Genetically manipulated progenitor/stem cells restore function to the infarcted heart via the SDF-1α/CXCR4 signaling pathway.

Wang Y, Luther K.

Prog Mol Biol Transl Sci. 2012;111:265-84. doi: 10.1016/B978-0-12-398459-3.00012-5. Review.

PMID:
22917235
16.

Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.

Weekes CD, Song D, Arcaroli J, Wilson LA, Rubio-Viqueira B, Cusatis G, Garrett-Mayer E, Messersmith WA, Winn RA, Hidalgo M.

Neoplasia. 2012 Aug;14(8):690-701.

17.

Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.

Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, Yasuda K, Kanzaki H.

Hum Reprod. 2012 Feb;27(2):523-30. doi: 10.1093/humrep/der405.

PMID:
22128293
18.

Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.

Plett PA, Frankovitz SM, Wolber FM, Abonour R, Orschell-Traycoff CM.

Exp Hematol. 2002 Sep;30(9):1061-9.

PMID:
12225798
19.

Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway.

Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G.

J Neurochem. 2001 Jun;77(5):1226-36.

Supplemental Content

Support Center